The healthcare and food and drinks conglomerate has invested £18m in its Lucozade and Ribena manufacturing facility in Coleford, Gloucestershire. The investment is for a new high speed bottling plant which will provide added capacity and improve cost efficiency by enabling GlaxoSmithKline’s (GSK’s) supply chain to be “minutely responsive to customer demand and removing…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login
